2025-524871-22-00已完成4 期
Study to assess the relative bioavailability of Neludolat versus YAZ in healthy female subjects.
Pevisal Group Farmaceutici S.r.l.1 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2026年7月7日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 24
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Alessandro Allegrini
Scientific
Pevisal Group Farmaceutici S.r.l.
研究点 (1)
Loading locations...
相似试验
已完成
1 期
A Phase 1 Study Evaluating Relative Bioavailability of Sprinkled Ritlecitinib in Applesauce, Yoghurt, and Strawberry Jam and Evaluating the Effect of Food on the Bioavailability of Ritlecitinib Intact Blend-In Capsule in Healthy Adult Participants.Alopecia Areata, Rheumatoid Arthritis, Vitiligo, Ulcerative Colitis and Crohn's Disease2022-502872-22-00Pfizer Inc.12
招募中
4 期
The pilot bioavailability study comparing the absorption of carbetocin (which is used as prevention of heavy bleeding after childbirth) in PABAL 100 μg/mL Solution for Injection when administered sublingually in the dose of 500 μg and intramuscularly in the dose of 100 μg.Not applicable (submitted trial is a bioavalability study in healthy participants).2025-524768-39-00Oxytone Bioscience B.V.4
进行中（未招募）
1 期
Evaluation of efficacy and bioavailability of ibuprofen lysinatePain on an inflammatory basis (otitis and otomastoiditis, adenite, cellulite, arthritis) and post-operative painMedDRA version: 21.0Level: PTClassification code 10050533Term: Pain assessmentSystem Organ Class: 10022891 - InvestigationsMedDRA version: 20.1Level: LLTClassification code 10063374Term: Pain scaleSystem Organ Class: 10022891 - InvestigationsEUCTR2019-000647-27-ITDicofarm S.p.A.84
招募中
1 期
A study to assess the safety, and blood levels of CTX-187 after single and repeated intravenous doses in healthy volunteers and patients with bacterial infectionBacterial Infection2026-525619-15-00Centauri Therapeutics Limited68
招募中
1 期
To evaluate the pharmacokinetics and safety of nolasibannot applicable (submitted trial is a pharmacokinetic study in healthy subjects)2025-523706-32-00ReproNovo ApS28